Skip to content
2000
Volume 22, Issue 1
  • ISSN: 1573-3963
  • E-ISSN: 1875-6336

Abstract

The novel Coronavirus Disease 2019 (COVID-19), caused by the SARS-CoV-2 virus, created a need for evidence-based guidelines for the evaluation, management, and follow-up after infection. Data have become rapidly available, creating a challenge for medical providers to stay abreast of the ever-evolving recommendations. This article, written collaboratively by pediatric cardiovascular experts, pediatricians, and sports medicine specialists, is focused on SARS-CoV- 2-related pediatric cardiac manifestations. It aims to provide a systematic review of high-yield literature related to all cardiovascular entities as a tool for primary pediatric clinicians to utilize as they consider the cardiac consequences of acute SARS-CoV-2 infection, MIS-C, vaccine-related myocarditis, return-to-play, and long COVID-19 syndrome.

© 2026 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cpr/10.2174/0115733963314978240923110844
2024-10-02
2025-12-16

  • From This Site

    /content/journals/cpr/10.2174/0115733963314978240923110844
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. World Health Organization. Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected: Interim guidance. Geneva: WHO;2020Available from: https://apps.who.int/iris/handle/10665/330854
  2. Centers for Disease Control Prevention National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. Interim clinical guidance for management of patients with confirmed coronavirus disease (COVID-19).2020Available from: https://stacks.cdc.gov/view/cdc/89980
  3. European Centre for Disease Prevention and Control. Guidance for wearing and removing personal protective equipment in healthcare settings for the care of patients with suspected or confirmed COVID-19. Stockholm, Sweden: ECDC; 2020. Available from: https://www.ecdc.europa.eu/en/publications-data/guidance-wearing-and-removing-personal-protective-equipment-healthcare-settings
  4. BhimrajA, Morgan RL, Shumaker AH Infectious Diseases Society of America Guidelines on the treatment and management of patients with COVID-19 (April 2020).Clin. Infect. Dis.2024787e83102
     [Google Scholar]
  5. National Institutes of Health. (n.d.). COVID-19 Treatment Guidelines. National Institutes of HealthRetrieved from https://www.ncbi.nlm.nih.gov/books/NBK570371/
  6. National Center for Biotechnology Information (US) National Center for Biotechnology Information (US).2024Available from: https://pubmed.ncbi.nlm.nih.gov/?term=pediatric%20covid&filter=years.2018-2023&sort=pubdate&sort_order=asc&timeline=expanded
  7. LuX. ZhangL. DuH. ZhangJ. LiY.Y. QuJ. ZhangW. WangY. BaoS. LiY. WuC. LiuH. LiuD. ShaoJ. PengX. YangY. LiuZ. XiangY. ZhangF. SilvaR.M. PinkertonK.E. ShenK. XiaoH. XuS. WongG.W.K. Chinese Pediatric Novel Coronavirus Study Team SARS-CoV-2 infection in children.N. Engl. J. Med.2020382171663166510.1056/NEJMc200507332187458
     [Google Scholar]
  8. BelayE.D. AbramsJ. OsterM.E. GiovanniJ. PierceT. MengL. PrezzatoE. BalachandranN. OpenshawJ.J. RosenH.E. KimM. RichardsonG. HandJ. Tobin-D’AngeloM. WilsonS. HartleyA. JonesC. KolsinJ. MohamedH. CollesZ. HammettT. PatelP. StiermanB. CampbellA.P. Godfred-CatoS. Trends in geographic and temporal distribution of US children with multisystem inflammatory syndrome during the COVID-19 pandemic.JAMA Pediatr.2021175883784510.1001/jamapediatrics.2021.063033821923
     [Google Scholar]
  9. AlsaiedT. TremouletA.H. BurnsJ.C. SaidiA. DionneA. LangS.M. NewburgerJ.W. de FerrantiS. FriedmanK.G. Review of cardiac involvement in multisystem inflammatory syndrome in children.Circulation20211431788810.1161/CIRCULATIONAHA.120.04983633166178
     [Google Scholar]
  10. Abi NassifT, Fakhri G, Younis NK. Cardiac manifestations in COVID-19 patients: A focus on the pediatric population.Can. J. Infect. Dis. Med. Microbiol.2021202115518979
     [Google Scholar]
  11. U.S. Department of Health and Human Services. (2023, May 9). Fact sheet: End of the COVID-19 public health emergency. Available from: https://www.hhs.gov/about/news/2023/05/09/fact-sheet-end-of-the-covid-19-public-health-emergency.html
  12. CDC updates and simplifies respiratory virus recommendations.2024Available from: https://www.cdc.gov/media/releases/2024/p0301-respiratory-virus.html
  13. ZhuF. AngJ.Y. COVID-19 infection in children: Diagnosis and management.Curr. Infect. Dis. Rep.2022244516210.1007/s11908‑022‑00779‑035431658
     [Google Scholar]
  14. HechingH.J. GoyalA. HarveyB. Malloy-WaltonL. FollansbeeC. McintoshA. ForshaD. Electrocardiographic changes in non-hospitalised children with COVID-19.Cardiol. Young202232121910191610.1017/S104795112100513834986922
     [Google Scholar]
  15. Disease Control and Prevention Centers for Disease Control and Prevention. Information for healthcare poviders about multisystem inflammatory syndrome in children (MIS-C).2021Available from: https://www.cdc.gov/mis/mis-c/hcp/index.html
  16. SteinM. Ashkenazi-HoffnungL. GreenbergD. DalalI. LivniG. ChapnickG. Stein-ZamirC. AshkenaziS. Hecht-SagieL. GrossmanZ. The burden of COVID-19 in children and its prevention by vaccination: A joint statement of the Israeli Pediatric Association and the Israeli Society for Pediatric Infectious Diseases.Vaccines20221018110.3390/vaccines1001008135062742
     [Google Scholar]
  17. SoleimaniA. SoleimaniZ. Presentation and outcome of congenital heart disease during COVID-19 pandemic: A review.Curr. Probl. Cardiol.202247110090510.1016/j.cpcardiol.2021.10090534172316
     [Google Scholar]
  18. Haji Esmaeil MemarE. PourakbariB. GorgiM. Sharifzadeh EkbataniM. NavaeianA. KhodabandehM. MahmoudiS. MamishiS. COVID-19 and congenital heart disease: A case series of nine children.World J. Pediatr.2021171717810.1007/s12519‑020‑00397‑733387256
     [Google Scholar]
  19. WHO. Tracking SARS-CoV-2 variants.2024Available from: https://www.who.int/activities/tracking-SARS-CoV-2- variants.
  20. WoodruffR.C. CampbellA.P. TaylorC.A. ChaiS.J. KawasakiB. MeekJ. AndersonE.J. WeigelA. MonroeM.L. ReegL. ByeE. SosinD.M. MuseA. BennettN.M. BillingL.M. SuttonM. TalbotH.K. McCaffreyK. PhamH. PatelK. WhitakerM. McMorrowM. HaversF. Risk factors for severe COVID-19 in children.Pediatrics20221491e202105341810.1542/peds.2021‑05341834935038
     [Google Scholar]
  21. FeldsteinL.R. TenfordeM.W. FriedmanK.G. NewhamsM. RoseE.B. DapulH. SomaV.L. MadduxA.B. MouraniP.M. BowensC. MaamariM. HallM.W. RiggsB.J. GiulianoJ.S.Jr SinghA.R. LiS. KongM. SchusterJ.E. McLaughlinG.E. SchwartzS.P. WalkerT.C. LoftisL.L. HobbsC.V. HalasaN.B. DoymazS. BabbittC.J. HumeJ.R. GertzS.J. IrbyK. ClouserK.N. CvijanovichN.Z. BradfordT.T. SmithL.S. HeidemannS.M. ZackaiS.P. WellnitzK. NofzigerR.A. HorwitzS.M. CarrollR.W. RowanC.M. TarquinioK.M. MackE.H. FitzgeraldJ.C. CoatesB.M. JacksonA.M. YoungC.C. SonM.B.F. PatelM.M. NewburgerJ.W. RandolphA.G. Overcoming COVID-19 Investigators Characteristics and outcomes of US children and adolescents with multisystem inflammatory syndrome in children (MIS-C) compared with severe acute COVID-19.JAMA2021325111074108710.1001/jama.2021.209133625505
     [Google Scholar]
  22. VasichkinaE. AlekseevaD. KudryavtsevI. GlushkovaA. StarshinovaA.Y. MalkovaA. KudlayD. StarshinovaA. COVID-19 heart lesions in children: Clinical, diagnostic and immunological changes.Int. J. Mol. Sci.2023242114710.3390/ijms2402114736674665
     [Google Scholar]
  23. CrawfordR.L. BolinE.H. ProdhanP. RennoM.S. KnechtK.R. Variable presentation of COVID-19 in pediatric patients.Pediatr. Infect. Dis. J.2021402e88e9010.1097/INF.000000000000297433433162
     [Google Scholar]
  24. DionneA. FriedmanK.G. YoungC.C. NewhamsM.M. KucukakS. JacksonA.M. FitzgeraldJ.C. SmallcombL.S. HeidemannS. McLaughlinG.E. IrbyK. BradfordT.T. HorwitzS.M. LoftisL.L. SomaV.L. RowanC.M. KongM. HalasaN.B. TarquinioK.M. SchwarzA.J. HumeJ.R. GertzS.J. ClouserK.N. CarrollC.L. WellnitzK. CullimoreM.L. DoymazS. LevyE.R. TyppoK.V. LansellA.N. ButlerA.D. KueblerJ.D. ZambranoL.D. CampbellA.P. PatelM.M. RandolphA.G. NewburgerJ.W. Overcoming COVID-19 Investigators Tachyarrhythmias during hospitalization for COVID-19 or multisystem inflammatory syndrome in children and adolescents.J. Am. Heart Assoc.20221120e02591510.1161/JAHA.122.02591536250670
     [Google Scholar]
  25. UpToDate. Nirmatrelvir and ritonavir: Pediatric drug information. Available from: https://www.uptodate.com/contents/nirmatrelvir-and-ritonavir-pediatric-drug-information?search=sars%20cov%202%20treatment&topicRef=134695&source=see_link
  26. AndrewsH.S. HermanJ.D. GandhiR.T. Treatments for COVID-19.Annu. Rev. Med.202475114515710.1146/annurev‑med‑052422‑02031637722709
     [Google Scholar]
  27. RiphagenS. GomezX. Gonzalez-MartinezC. WilkinsonN. TheocharisP. Hyperinflammatory shock in children during COVID-19 pandemic.Lancet2020395102371607160810.1016/S0140‑6736(20)31094‑132386565
     [Google Scholar]
  28. Centers for Disease Control and Prevention. Health advisory: Multisystem inflammatory syndrome in children (MIS-C) associated with coronavirus disease 2019 (COVID-19). 2020. Available from: https://archive.cdc.gov/emergency_cdc_gov/han/2020/han 00432.asp
  29. Centers for Disease Control and Prevention. Health department-reported cases of multisystem inflammatory syndrome in children (MIS-C) in the United States. 2020. Available from: https://stacks.cdc.gov/view/cdc/105208
  30. Centers for Disease Control and Prevention. Information for healthcare providers about multisystem inflammatory syndrome in children (MIS-C). 2020. Available from: https://archive.cdc.gov/www_cdc_gov/mis/mis-c/hcp/index.html
  31. SonM.B.F. BurnsJ.C. NewburgerJ.W. A new definition for multisystem inflammatory syndrome in children.Pediatrics20231513e202206030210.1542/peds.2022‑06030236624565
     [Google Scholar]
  32. MillerA.D. ZambranoL.D. YousafA.R. AbramsJ.Y. MengL. WuM.J. MelgarM. OsterM.E. Godfred CatoS.E. BelayE.D. CampbellA.P. MIS-C Surveillance Authorship Group Multisystem inflammatory syndrome in children-united states, February 2020-July 2021.Clin. Infect. Dis.2022751e1165e117510.1093/cid/ciab100734864955
     [Google Scholar]
  33. MillerA.D. YousafA.R. BornsteinE. WuM.J. LindseyK. MelgarM. OsterM.E. ZambranoL.D. CampbellA.P. Multisystem inflammatory syndrome in children during severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) delta and omicron variant circulation—United States, July 2021–January 2022.Clin. Infect. Dis.202275Suppl. 2S303S30710.1093/cid/ciac47135684958
     [Google Scholar]
  34. DufortE.M. KoumansE.H. ChowE.J. RosenthalE.M. MuseA. RowlandsJ. BarrancoM.A. MaxtedA.M. RosenbergE.S. EastonD. UdoT. KumarJ. PulverW. SmithL. HuttonB. BlogD. ZuckerH. Multisystem inflammatory syndrome in children in New York state.N. Engl. J. Med.2020383434735810.1056/NEJMoa202175632598830
     [Google Scholar]
  35. FeldsteinL.R. RoseE.B. HorwitzS.M. CollinsJ.P. NewhamsM.M. SonM.B.F. NewburgerJ.W. KleinmanL.C. HeidemannS.M. MartinA.A. SinghA.R. LiS. TarquinioK.M. JaggiP. OsterM.E. ZackaiS.P. GillenJ. RatnerA.J. WalshR.F. FitzgeraldJ.C. KeenaghanM.A. AlharashH. DoymazS. ClouserK.N. GiulianoJ.S.Jr GuptaA. ParkerR.M. MadduxA.B. HavaladV. RamsinghS. BukulmezH. BradfordT.T. SmithL.S. TenfordeM.W. CarrollC.L. RiggsB.J. GertzS.J. DaubeA. LansellA. Coronado MunozA. HobbsC.V. MarohnK.L. HalasaN.B. PatelM.M. RandolphA.G. Overcoming COVID-19 Investigators CDC COVID-19 Response Team Multisystem inflammatory syndrome in US children and adolescents.N. Engl. J. Med.2020383433434610.1056/NEJMoa202168032598831
     [Google Scholar]
  36. Centers for Disease Control and Prevention. Health department-reported cases of multisystem inflammatory syndrome in children (MIS-C) in the United States.2024Available from: https://covid.cdc.gov/covid-data-tracker/#mis-national- surveillance.
  37. Laird-GionJ. DionneA. GauvreauK. BakerA. Day-LewisM. de FerrantiS. FriedmanK. KhanN. MahantaS. SonM.B. SperottoF. NewburgerJ.W. MIS-C across three SARS-CoV-2 variants: Changes in COVID-19 testing and clinical characteristics in a cohort of U.S. children.Eur. J. Pediatr.202318262865287210.1007/s00431‑023‑04968‑437055630
     [Google Scholar]
  38. DoveM.L. JaggiP. KellemanM. AbualiM. AngJ.Y. BallanW. BasuS.K. CampbellM.J. ChikkabyrappaS.M. ChoueiterN.F. ClouserK.N. CorwinD. EdwardsA. GertzS.J. GhassemzadehR. JarrahR.J. KatzS.E. KnutsonS.M. KueblerJ.D. LighterJ. MikesellC. MongkolrattanothaiK. MortonT. NakraN.A. OliveroR. OsborneC.M. PanesarL.E. ParsonsS. PatelR.M. SchuetteJ. ThackerD. TremouletA.H. VidwanN.K. OsterM.E. Multisystem inflammatory syndrome in children: Survey of protocols for early hospital evaluation and management.J. Pediatr.2021229334010.1016/j.jpeds.2020.10.02633075369
     [Google Scholar]
  39. JainS. HeF. BrownK. BurnsJ.C. TremouletA.H. Multisystem Inflammatory Syndrome therapies in children (MISTIC): A randomized trial.Contemp. Clin. Trials Commun.20233210106010.1016/j.conctc.2023.10106036694613
     [Google Scholar]
  40. ColeL.D. OsborneC.M. SilveiraL.J. RaoS. LockwoodJ.M. KunkelM.J. MacBrayneC.E. HeizerH.R. AndersonM.S. JoneP.N. DominguezS.R. IVIG compared with IVIG plus infliximab in multisystem inflammatory syndrome in children.Pediatrics20211486e202105270210.1542/peds.2021‑05270234548377
     [Google Scholar]
  41. MarshallM. FergusonI.D. LewisP. JaggiP. GagliardoC. CollinsJ.S. ShaughnessyR. CaronR. FussC. CorbinK.J.E. EmurenL. FahertyE. HallE.K. Di PentimaC. OsterM.E. PaintsilE. SiddiquiS. TimchakD.M. Guzman-CottrillJ.A. Symptomatic acute myocarditis in 7 adolescents after Pfizer-BioNTech COVID-19 vaccination.Pediatrics20211483e202105247810.1542/peds.2021‑05247834088762
     [Google Scholar]
  42. PatoneM. MeiX.W. HandunnetthiL. DixonS. ZaccardiF. Shankar-HariM. WatkinsonP. KhuntiK. HarndenA. CouplandC.A.C. ChannonK.M. MillsN.L. SheikhA. Hippisley-CoxJ. Risk of myocarditis after sequential doses of COVID-19 vaccine and SARS-CoV-2 infection by age and sex.Circulation20221461074375410.1161/CIRCULATIONAHA.122.05997035993236
     [Google Scholar]
  43. PillayJ, Gaudet L, Wingert A. Incidence, risk factors, natural history, and hypothesised mechanisms of myocarditis and pericarditis following COVID-19 vaccination: Living evidence syntheses and review.bmj202237810.1136/bmj‑2021‑069445
     [Google Scholar]
  44. FatimaM. KhanM.H.A. AliM.S. OsamaM. CheemaH.A. AhmedA. NisarA. MuradM.W. FarooqH. Aemaz Ur RehmanM. SwedS. AkbarU.A. Development of myocarditis and pericarditis after COVID-19 vaccination in children and adolescents: A systematic review.Clin. Cardiol.202346324325910.1002/clc.2396536594165
     [Google Scholar]
  45. ShayD.K. ShimabukuroT.T. DeStefanoF. Myocarditis occurring after immunization with mRNA-based COVID-19 vaccines.JAMA Cardiol.20216101115111710.1001/jamacardio.2021.282134185047
     [Google Scholar]
  46. TruongD.T. DionneA. MunizJ.C. McHughK.E. PortmanM.A. LambertL.M. ThackerD. EliasM.D. LiJ.S. Toro-SalazarO.H. AndersonB.R. AtzA.M. BohunC.M. CampbellM.J. ChrisantM. D’AddeseL. DummerK.B. ForshaD. FrankL.H. FroschO.H. GelehrterS.K. GigliaT.M. HebsonC. JainS.S. JohnstonP. KrishnanA. LombardiK.C. McCrindleB.W. MitchellE.C. MiyataK. MizziT. ParkerR.M. PatelJ.K. RonaiC. SabatiA.A. SchauerJ. Sexson TejtelS.K. SheaJ.R. ShekerdemianL.S. SrivastavaS. Votava-SmithJ.K. WhiteS. NewburgerJ.W. Clinically suspected myocarditis temporally related to COVID-19 vaccination in adolescents and young adults: Suspected myocarditis after COVID-19 vaccination.Circulation2022145534535610.1161/CIRCULATIONAHA.121.05658334865500
     [Google Scholar]
  47. HauseA.M. MarquezP. ZhangB. SuJ.R. MyersT.R. GeeJ. PanchanathanS.S. ThompsonD. ShimabukuroT.T. ShayD.K. Safety monitoring of bivalent COVID-19 mRNA vaccine booster doses among children aged 5–11 years — United States, 2023.MMWR Morb. Mortal. Wkly. Rep.2023722394310.15585/mmwr.mm7202a536634021
     [Google Scholar]
  48. EliasM.D. TruongD.T. OsterM.E. TrachtenbergF.L. MuX. JoneP.N. MitchellE.C. DummerK.B. Sexson TejtelS.K. OsakweO. ThackerD. SuJ.A. BradfordT.T. BurnsK.M. CampbellM.J. ConnorsT.J. D’AddeseL. ForshaD. FroschO.H. GigliaT.M. GoodellL.R. HandlerS.S. HasbaniK. HebsonC. KrishnanA. LangS.M. McCrindleB.W. McHughK.E. MorganL.M. PayneR.M. SabatiA. SagivE. SanilY. SerranoF. NewburgerJ.W. DionneA. PearsonG. PembertonV. EgersonD.A. MahonyL. MillerJ. HayesK. Crosby-ThompsonA. AmarnathA. AmbrosoliJ. ArtisC. RubioK. KinhikarC. MarshallA. MbiydzenyuyD. KazlovaV. HuC. EyobL. SlaytonB. DiStefanoL. HonigJ. BowieT. NeroR. BirminghamE. RoweR. JoyceM. GallagherC. BowmanD. ZhangM. MooneyA. DragulescuA. LamC. YeungR. GamulkaB. BaintonJ. RollandM. WalterP. MahantaS. GiorgioT. KhanN. BakerA. BuckleyL.J. JonesJ. WatsonL.T. ClarkeA. LeekT-S-A. OravG. MorrisonT. LuptonK. SylvesterD. AlbizemD. LanzilottaK. MarksG. JohnsonM. BickfordM. LambertL. FagateleL. CurlessA. RussellM. DomanT. AlmaguerM. DuganL. RathgeK. SeibertE. StumpfM. HowellJ. PatelJ. MitscherG. BurnettM. Sanders-LewisK. EvansB. MahleW.T. KochilasL. RudowM. GentryS. LeK. TaylorC. ShekerdemianL. MoussiE. PenaS. PignatelliR. GarubaO. LiuA. AndersonB. SanchezC. MartyrosyanK. SzmuszkoviczJ.R. ChengA.L. MohandasS. Votava-SmithJ.K. WangS. WongP.C. SharmaK. MartinezM. MohazabniaP. RojasW. BlockJ. ColeR. MaldonadoJ. SrivastavaS. ProsperoC. ZadokarV. WilliamsE. CarrM. Van’t HofK. SullivanC. PortmanM.A. KajimotoH. NairD.G. BeckleyM.A. PancheriJ. CraneK. HarahshehA. BerulC. OlivieriL. HavertyM. FetchA. SchottC. LittS. NelsonJ. HiteM. GlassmeyerI. NowlenT. HerzbergA. StackS. PorcheJ. ParkS. JohnsonA. ShaktiD. ParnellA.S. WeilandM.D. ParkerP. KertisJ.A. HobbsC.V. HowardC.M. SavadkarS. WorrellA.E. BarrM.R. WilliamsH. GordyD. VemulaP. WhiteZ. MoratoJ.G.S. TylerS. HockK. SykesM. OwadaC. Lemus RangelM. MaciasI. SinghG. AggarwalS. Williams-FarrC. SullivanN. AlmasnaahA. UndyalaV. HannahB. McCallM. StrelowJ. DowneyR. ShafferK. CastleberryC. PomeroyL. AmsellemR. ShamailovaO. JohnstonM. MunizJ.C. ChangM. SheaR. DavisM. ChrisantM. KatzD. BartonN. AlabyD. SmithP. FriedmanK. SperottoF. MarcusE. FerreiraR. McGeogheganP. TaylorM. GermannJ. PowellA. MackieA. GobburuJ. HunsbergerS. McQuillenP. SpaederM. AtkinsD. BrobergC. DriscollD.J. EvansF. HunsbergerS.A. JohnsonL-M. KnightT.J. LipkinP. SaulJ.P. Pediatric Heart Network MUSIC Study Investigators Examination of adverse reactions after COVID-19 vaccination among patients with a history of multisystem inflammatory syndrome in children.JAMA Netw. Open202361e224898710.1001/jamanetworkopen.2022.4898736595296
     [Google Scholar]
  49. SonM.B.F. MurrayN. FriedmanK. YoungC.C. NewhamsM.M. FeldsteinL.R. LoftisL.L. TarquinioK.M. SinghA.R. HeidemannS.M. SomaV.L. RiggsB.J. FitzgeraldJ.C. KongM. DoymazS. GiulianoJ.S.Jr KeenaghanM.A. HumeJ.R. HobbsC.V. SchusterJ.E. ClouserK.N. HallM.W. SmithL.S. HorwitzS.M. SchwartzS.P. IrbyK. BradfordT.T. MadduxA.B. BabbittC.J. RowanC.M. McLaughlinG.E. YagerP.H. MaamariM. MackE.H. CarrollC.L. MontgomeryV.L. HalasaN.B. CvijanovichN.Z. CoatesB.M. RoseC.E. NewburgerJ.W. PatelM.M. RandolphA.G. Overcoming COVID-19 Investigators Multisystem inflammatory syndrome in children — Initial therapy and outcomes.N. Engl. J. Med.20213851233410.1056/NEJMoa210260534133855
     [Google Scholar]
  50. ZaffanelloM. PiacentiniG. NosettiL. GanzarolliS. FranchiniM. Thrombotic risk in children with COVID-19 infection: A systematic review of the literature.Thromb. Res.2021205929810.1016/j.thromres.2021.07.01134293539
     [Google Scholar]
  51. OsterM.E. ShayD.K. SuJ.R. GeeJ. CreechC.B. BroderK.R. EdwardsK. SoslowJ.H. DendyJ.M. SchlaudeckerE. LangS.M. BarnettE.D. RubergF.L. SmithM.J. CampbellM.J. LopesR.D. SperlingL.S. BaumblattJ.A. ThompsonD.L. MarquezP.L. StridP. WooJ. PugsleyR. Reagan-SteinerS. DeStefanoF. ShimabukuroT.T. Myocarditis cases reported after mRNA-based COVID-19 vaccination in the US from December 2020 to August 2021.JAMA2022327433134010.1001/jama.2021.2411035076665
     [Google Scholar]
  52. ChinS.E. BhavsarS.M. CorsonA. GhersinZ.J. KimH.S. Cardiac complications associated with COVID-19, MIS-C, and mRNA COVID-19 vaccination.Pediatr. Cardiol.202243348348810.1007/s00246‑022‑02851‑x35258639
     [Google Scholar]
  53. KohliU, Desai L, Chowdhary D. mRNA coronavirus disease 2019 vaccine-associated myopericarditis in adolescents: A survey study.J. Pediatr.2022243208213
     [Google Scholar]
  54. NafilyanV. BerminghamC.R. WardI.L. MorganJ. ZaccardiF. KhuntiK. StanboroughJ. BanerjeeA. DoidgeJ.C. Risk of death following COVID-19 vaccination or positive SARS-CoV-2 test in young people in England.Nat. Commun.2023141154110.1038/s41467‑023‑36494‑036973247
     [Google Scholar]
  55. ShahidR. TangW.H.W. KleinA.L. KwonD. AmdaniS. Is the mRNA COVID-19 vaccine safe in patients with a prior history of myocarditis?J. Card. Fail.202329110811110.1016/j.cardfail.2022.06.01135842104
     [Google Scholar]
  56. PuntmannV.O. CarerjM.L. WietersI. FahimM. ArendtC. HoffmannJ. ShchendryginaA. EscherF. Vasa-NicoteraM. ZeiherA.M. VehreschildM. NagelE. Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from coronavirus disease 2019 (COVID-19).JAMA Cardiol.20205111265127310.1001/jamacardio.2020.355732730619
     [Google Scholar]
  57. HuangL. ZhaoP. TangD. ZhuT. HanR. ZhanC. LiuW. ZengH. TaoQ. XiaL. Cardiac involvement in patients recovered from COVID-2019 identified using magnetic resonance imaging.JACC Cardiovasc. Imaging202013112330233910.1016/j.jcmg.2020.05.00432763118
     [Google Scholar]
  58. PhelanD. KimJ.H. ChungE.H. A game plan for the resumption of sport and exercise after coronavirus disease 2019 (COVID-19) infection.JAMA Cardiol.20205101085108610.1001/jamacardio.2020.213632402054
     [Google Scholar]
  59. SchellhornP. KlingelK. BurgstahlerC. Return to sports after COVID-19 infection.Eur Heart J 2020; 41(46): 4382-4.10.1093/eurheartj/ehaa448
     [Google Scholar]
  60. BaggishA.L. LevineB.D. Icarus and sports after COVID 19: Too close to the sun?Circulation2020142761561710.1161/CIRCULATIONAHA.120.04833532516032
     [Google Scholar]
  61. DanielsC.J. RajpalS. GreenshieldsJ.T. RosenthalG.L. ChungE.H. TerrinM. JeudyJ. MattsonS.E. LawI.H. BorchersJ. KovacsR. KovanJ. RifatS.F. AlbrechtJ. BentoA.I. AlbersL. BernhardtD. DayC. HechtS. HipskindA. MjaanesJ. OlsonD. RooksY.L. SomersE.C. TongM.S. WisinskiJ. WomackJ. EsopenkoC. KratochvilC.J. RinkL.D. SimonettiO. ZarebaK. BhattiS. AddisonD. ObarskiT. DaoudE. GrangerM. SmartS. Mayercin-JohnsonJ. SubramanianP. GlittJ. MitchellD. ChumitaR. MumfordA. GarciaA. GarrisL. LiuH. HatfieldB. ZhangY. BoersmaD. SchladerZ. GoodwinS. PortN. ZuidemaT. MaldonadoJ. EckhardtL. ReederS. BakerM. SebastianelliW. WadlingerR. MillardR. BoshaP. SundayH. SteeleD. ChaudhryA. SmithS. PfeifferM. KellermanJ. BillyG. KrystofiakJ. EimerM. Big Ten COVID-19 Cardiac Registry Investigators Prevalence of clinical and subclinical myocarditis in competitive athletes with recent SARS-CoV-2 infection: Results from the big ten COVID-19 cardiac registry.JAMA Cardiol.2021691078108710.1001/jamacardio.2021.206534042947
     [Google Scholar]
  62. RajpalS. TongM.S. BorchersJ. ZarebaK.M. ObarskiT.P. SimonettiO.P. DanielsC.J. Cardiovascular magnetic resonance findings in competitive athletes recovering from COVID-19 infection.JAMA Cardiol.20216111611832915194
     [Google Scholar]
  63. GagelAC, Sharma G, Blumenthal RS, Martinez MW. COVID-19, myocarditis, and cardiac MRI in athletes: Distinguishing signal from noise. American College of Cardioilogy.2021Available from: https://www.acc.org/latest-in-cardiology/articles/2021/09/28/18/07/covid-19-myocarditis-and-cardiac-mri-in-athletes
  64. ArticoJ. ShiwaniH. MoonJ.C. GoreckaM. McCannG.P. RoditiG. MorrowA. MangionK. LukaschukE. ShanmuganathanM. MillerC.A. ChiribiriA. PrasadS.K. AdamR.D. SinghT. Bucciarelli-DucciC. DawsonD. KnightD. FontanaM. ManistyC. TreibelT.A. LeveltE. ArnoldR. MacfarlaneP.W. YoungR. McConnachieA. NeubauerS. PiechnikS.K. DaviesR.H. FerreiraV.M. DweckM.R. BerryC. GreenwoodJ.P. OxAMI (Oxford Acute Myocardial Infarction Study) Investigators; COVID-HEART Investigators† Myocardial involvement after hospitalization for COVID-19 complicated by troponin elevation: A prospective, multicenter, observational study.Circulation2023147536437410.1161/CIRCULATIONAHA.122.06063236705028
     [Google Scholar]
  65. KimJ.H. LevineB.D. PhelanD. EmeryM.S. MartinezM.W. ChungE.H. ThompsonP.D. BaggishA.L. Coronavirus disease 2019 and the athletic heart: Emerging perspectives on pathology, risks, and return to play.JAMA Cardiol.20216221922710.1001/jamacardio.2020.589033104154
     [Google Scholar]
  66. GluckmanT.J. BhaveN.M. AllenL.A. ChungE.H. SpatzE.S. AmmiratiE. BaggishA.L. BozkurtB. CornwellW.K.III HarmonK.G. KimJ.H. LalaA. LevineB.D. MartinezM.W. OnumaO. PhelanD. PuntmannV.O. RajpalS. TaubP.R. VermaA.K. Writing Committee 2022 ACC expert consensus decision pathway on cardiovascular sequelae of COVID-19 in adults: Myocarditis and other myocardial involvement, post-acute sequelae of SARS-CoV-2 infection, and return to play.J. Am. Coll. Cardiol.202279171717175610.1016/j.jacc.2022.02.00335307156
     [Google Scholar]
  67. DeanP.N. JacksonLB. ParidonSM. Returning to play after coronavirus infection: Pediatric cardiologists’ perspective.Am Coll Cardiol202016
     [Google Scholar]
  68. D’AscenziF. CastellettiS. AdamiP.E. CavarrettaE. Sanz-de la GarzaM. MaestriniV. BiffiA. KantorP. PielesG. VerhagenE. TiberiM. HanssenH. PapadakisM. NiebauerJ. HalleM. Cardiac screening prior to return to play after SARS-CoV-2 infection: Focus on the child and adolescent athlete: A Clinical Consensus Statement of the Task Force for Childhood Health of the European Association of Preventive Cardiology.Eur. J. Prev. Cardiol.202229162120212410.1093/eurjpc/zwac18036059208
     [Google Scholar]
  69. SalmanD, Vishnubala D, Le Feuvre P. Returning to physical activity after COVID-19.bmj202137210.1136/bmj.m4721
     [Google Scholar]
  70. American Academy of Pediatrics American Academy of Pediatrics. COVID-19 interim guidance: Return to sports and physical activity.2022Available from: https://www.aap.org/en/pages/2019-novel-coronavirus-covid-19-infections/clinical-guidance/covid-19-interim-guidance-return-to-sports/
  71. MaronB.J. UdelsonJ.E. BonowR.O. NishimuraR.A. AckermanM.J. EstesN.A.III CooperL.T.Jr LinkM.S. MaronM.S. American Heart Association Electrocardiography and Arrhythmias Committee of Council on Clinical Cardiology, Council on Cardiovascular Disease in Young, Council on Cardiovascular and Stroke Nursing, Council on Functional Genomics and Translational Biology, and American College of Cardiology Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: Task force 3: Hypertrophic cardiomyopathy, arrhythmogenic right ventricular cardiomyopathy and other cardiomyopathies, and myocarditis: A scientific statement from the American Heart Association and American College of Cardiology.Circulation201513222e273e28026621644
     [Google Scholar]
  72. DreznerJ.A. HeinzW.M. AsifI.M. BattenC.G. FieldsK.B. RaukarN.P. ValentineV.D. WalterK.D. Cardiopulmonary considerations for high school student-athletes during the COVID-19 pandemic: NFHS-AMSSM guidance statement.Sports Health202012545946110.1177/194173812094149032640879
     [Google Scholar]
  73. ElliottN. MartinR. HeronN. ElliottJ. GrimsteadD. BiswasA. Infographic. Graduated return to play guidance following COVID-19 infection.Br. J. Sports Med.202054191174117510.1136/bjsports‑2020‑10263732571796
     [Google Scholar]
  74. PetekB.J. MoulsonN. DreznerJ.A. HarmonK.G. KliethermesS.A. ChurchillT.W. PatelM.R. BaggishA.L. AsifI.M. BaggishA.L. BorchersJ. DreznerJ.A. EdenfieldK.M. EmeryM.S. GoerlK. HainlineB. HarmonK.G. JoneP-N. KimJ.H. KliethermesS. KrausW.E. LampertR. LeiszlerM. LevineB.D. MartinezM.W. MoulsonN. O’ConnorF.G. PatelM.R. PetekB.J. PhelanD. RinkL.D. TaylorH.A. AdeC. AiyerA. AlfadhliJ. AmaradioC. AndersonS. Arlis-MayorS. AubryJ.S. AustinA. BalcikB.J. BeaverT. BenitezN. BerkstresserB. BestT.M. BohonT. BonnetJ.P. BoyingtonE. BrayJ. BryantJ. BytomskiJ. CarnahanS. ChamberlainR. ChartersS. ChillN. ClarkD.E. ComeauD. CookL.E. CoreyD. CostaA. CrowtherM. DaliaT. DavidsonC. DavittK. MauriceA.D.S. DeanP.N. DendyJ.M. DeZenzoK. DimitrisC. DoperakJ. DuffautC. FafaraC. FahyK. FerderberJ. FinnM. FishF.A. FitchR.W. GalanteA. GerltT. GestA. GilsonC. GoldbergerJ. GoldmanJ. GroezingerE. GuinJ.R. HalsethH. HareJ. HarnessB. HatamiyaN. HaylettJ. HazenN. HughesS.G. HiroiY. HockenbrockA. HonsvallA. HoppJ. HowardJ. HubaS. HusainiM. HustonL. HwangC. IrvinL. IvenV.G. JonesR. JoyceD. KarlsonK. KentJ. KleinC.F. KlenckC. KirkM. KnightJ. KnippaL. KnutsonM. KovacsL.E. KuscherY. KussmanA. LandrethC. LeuA. LothianD. LoweryM. LukjanczukA. MacKnightJ.M. MageeL.M. MagnusonM-L. MaresA.V. MarquezA. McKinleyG. MeesterS. MeierM. MellacheruvuP. MilesC. MillerE. MillerH. MitraniR. MonseauA.J. MooreheadB. MyerburgR.J. MytykG. NarverA. NattivA. NurL. OrganB.E. PendergastM. PettroneF.A. PierceJ. PoddarS.K. PriestmanD. QuinnI. ReifsteckF. RestivoM. RobinsonJ.B. RoeR. RosamondT. Rubertino ShearerC. RiverosD. RuedaM. SakamotoT. SchnebelB. ShahA.B. ShahtajiA. ShannonK. Sheridan-YoungP. SoslowJ.H. StatutaS.M. StovakM. TarsiciA. TaylorK.S. TerrellK. ThomasonM. TsoJ. VigilD. WangF. WinninghamJ. ZornS.T. ORCCA Investigators Cardiovascular outcomes in collegiate athletes after SARS-CoV-2 infection: 1-year follow-up from the outcomes registry for cardiac conditions in athletes.Circulation2022145221690169210.1161/CIRCULATIONAHA.121.05827235545946
     [Google Scholar]
  75. Brugler YontsA. Pediatric long-COVID: A review of the definition, epidemiology, presentation, and pathophysiology.Pediatr. Ann.20225111e416e42036343180
     [Google Scholar]
  76. Lopez-LeonS. Wegman-OstroskyT. PerelmanC. SepulvedaR. RebolledoP.A. CuapioA. VillapolS. More than 50 long-term effects of COVID-19: A systematic review and meta-analysis.Sci. Rep.20211111614410.1038/s41598‑021‑95565‑834373540
     [Google Scholar]
  77. PiazzaM. Di CiccoM. PecoraroL. GhezziM. PeroniD. ComberiatiP. Long COVID-19 in children: From the pathogenesis to the biologically plausible roots of the syndrome.Biomolecules202212455610.3390/biom1204055635454144
     [Google Scholar]
  78. World Health Organization WHO. A clinical case definition for post COVID-19 condition in children and adolescents by expert consensus.2023Available from: https://www.who.int/publications/i/item/WHO-2019-nCoV- Post- COVID-19-condition-CA-Clinical-case-definition-2023-1
  79. NICE. COVID-19 rapid guideline: Managing the long-term effects of COVID-19. London: National Institute for Health and Care Excellence (NICE).202433555768
     [Google Scholar]
  80. XieY. XuE. BoweB. Al-AlyZ. Long-term cardiovascular outcomes of COVID-19.Nat. Med.202228358359010.1038/s41591‑022‑01689‑335132265
     [Google Scholar]
  81. Lopez-LeonS. Wegman-OstroskyT. Ayuzo del ValleN.C. PerelmanC. SepulvedaR. RebolledoP.A. CuapioA. VillapolS. Long-COVID in children and adolescents: A systematic review and meta-analyses.Sci. Rep.2022121995010.1038/s41598‑022‑13495‑535739136
     [Google Scholar]
  82. KompaniyetsL. Bull-OttersonL. BoehmerT.K. BacaS. AlvarezP. HongK. HsuJ. HarrisA.M. GundlapalliA.V. SaydahS. Post- COVID-19 symptoms and conditions among children and adolescents—United States, March 1, 2020–January 31, 2022.MMWR Morb. Mortal. Wkly. Rep.2022713199399910.15585/mmwr.mm7131a335925799
     [Google Scholar]
  83. ChakrabortyA. JohnsonJ.N. SpagnoliJ. AminN. MccoyM. SwaminathanN. YohannanT. PhilipR. Long-term cardiovascular outcomes of multisystem inflammatory syndrome in children associated with COVID-19 using an institution based algorithm.Pediatr. Cardiol.202344236738010.1007/s00246‑022‑03020‑w36214896
     [Google Scholar]
  84. NalbandianA. SehgalK. GuptaA. MadhavanM.V. McGroderC. StevensJ.S. CookJ.R. NordvigA.S. ShalevD. SehrawatT.S. AhluwaliaN. BikdeliB. DietzD. Der-NigoghossianC. Liyanage-DonN. RosnerG.F. BernsteinE.J. MohanS. BeckleyA.A. SeresD.S. ChoueiriT.K. UrielN. AusielloJ.C. AcciliD. FreedbergD.E. BaldwinM. SchwartzA. BrodieD. GarciaC.K. ElkindM.S.V. ConnorsJ.M. BilezikianJ.P. LandryD.W. WanE.Y. Post-acute COVID-19 syndrome.Nat. Med.202127460161510.1038/s41591‑021‑01283‑z33753937
     [Google Scholar]
  85. ZhengY.B. ZengN. YuanK. TianS.S. YangY.B. GaoN. ChenX. ZhangA.Y. KondratiukA.L. ShiP.P. ZhangF. SunJ. YueJ.L. LinX. ShiL. LalvaniA. ShiJ. BaoY.P. LuL. Prevalence and risk factor for long COVID in children and adolescents: A meta-analysis and systematic review.J. Infect. Public Health202316566067210.1016/j.jiph.2023.03.00536931142
     [Google Scholar]
  86. TrapaniG. VerlatoG. BertinoE. MaioccoG. VesentiniR. SpadavecchiaA. DessìA. FanosV. Long COVID-19 in children: An Italian cohort study.Ital. J. Pediatr.20224818310.1186/s13052‑022‑01282‑x35659358
     [Google Scholar]
  87. DaniM. DirksenA. TaraborrelliP. TorocastroM. PanagopoulosD. SuttonR. LimP.B. Autonomic dysfunction in ‘long COVID’: Rationale, physiology and management strategies.Clin. Med.2021211e63e6710.7861/clinmed.2020‑089633243837
     [Google Scholar]
  88. BlitshteynS. WhitesonJ.H. AbramoffB. AzolaA. BartelsM.N. Bhavaraju-SankaR. ChungT. FlemingT.K. HenningE. MiglisM.G. SampselS. SilverJ.K. TostoJ. Verduzco-GutierrezM. PutrinoD. Multi-disciplinary collaborative consensus guidance statement on the assessment and treatment of autonomic dysfunction in patients with post-acute sequelae of SARS-CoV-2 infection (PASC).PMR202214101270129110.1002/pmrj.1289436169154
     [Google Scholar]
  89. RoweP.C. UnderhillR.A. FriedmanK.J. GurwittA. MedowM.S. SchwartzM.S. SpeightN. StewartJ.M. VallingsR. RoweK.S. Myalgic encephalomyelitis/chronic fatigue syndrome diagnosis and management in young people: A primer.Front Pediatr.2017512110.3389/fped.2017.0012128674681
     [Google Scholar]
  90. SendzikaiteS. HeyingR. MilanesiO. HanseusK. Michel-BehnkeI. COVID-19 FAQs in paediatric and congenital cardiology: AEPC position paper.Cardiol. Young202131334435110.1017/S104795112000502833407975
     [Google Scholar]
  91. StrahDD, Kowalek KA, Weinberger K. Worse hospital outcomes for children and adults with COVID-19 and congenital heart disease.Pediatr. Cardiol.2022433541634633493
     [Google Scholar]
  92. MaloneL.A. MorrowA. ChenY. CurtisD. de FerrantiS.D. DesaiM. FlemingT.K. GigliaT.M. HallT.A. HenningE. JadhavS. JohnstonA.M. KathirithambyD.R.C. KokorelisC. LachenauerC. LiL. LinH.C. LockeT. MacArthurC. MannM. McGrath-MorrowS.A. NgR. OhlmsL. RisenS. SadreameliS.C. SampselS. TejtelS.K.S. SilverJ.K. SimoneauT. SroujiR. SwamiS. TorbeyS. GutierrezM.V. WilliamsC.N. ZimmermanL.A. VazL.E. Multi-disciplinary collaborative consensus guidance statement on the assessment and treatment of post acute sequelae of SARS-CoV-2 infection (PASC) in children and adolescents.PM R202214101241126910.1002/pmrj.1289036169159
     [Google Scholar]
  93. WhitesonJ.H. AzolaA. BarryJ.T. BartelsM.N. BlitshteynS. FlemingT.K. McCauleyM.D. NealJ.D. PillarisettiJ. SampselS. SilverJ.K. TerzicC.M. TostoJ. Verduzco-GutierrezM. PutrinoD. Multi-disciplinary collaborative consensus guidance statement on the assessment and treatment of cardiovascular complications in patients with post-acute sequelae of SARS-CoV-2 infection (PASC).PM R202214785587810.1002/pmrj.1285935657351
     [Google Scholar]
  94. LahrmannH. CortelliP. HilzM. MathiasC.J. StruhalW. TassinariM. EFNS guidelines on the diagnosis and management of orthostatic hypotension.Eur. J. Neurol.200613993093610.1111/j.1468‑1331.2006.01512.x16930356
     [Google Scholar]
  95. SheldonR.S. GrubbB.P.II OlshanskyB. ShenW.K. CalkinsH. BrignoleM. RajS.R. KrahnA.D. MorilloC.A. StewartJ.M. SuttonR. SandroniP. FridayK.J. HachulD.T. CohenM.I. LauD.H. MayugaK.A. MoakJ.P. SandhuR.K. KanjwalK. 2015 heart rhythm society expert consensus statement on the diagnosis and treatment of postural tachycardia syndrome, inappropriate sinus tachycardia, and vasovagal syncope.Heart Rhythm2015126e41e6310.1016/j.hrthm.2015.03.02925980576
     [Google Scholar]
  96. TruongD.T. TrachtenbergF.L. PearsonG.D. DionneA. EliasM.D. FriedmanK. HayesK.H. MahonyL. McCrindleB.W. OsterM.E. PembertonV. PowellA.J. RussellM.W. ShekerdemianL.S. SonM.B. TaylorM. NewburgerJ.W. DionneA. EliasM.D. GigliaT.M. McHughK.E. AtzA.M. PletzerS.A. TruongD.T. RussellM.W. LangS.M. PayneR.M. PatelJ.K. OsterM.E. ShekerdemianL.S. PignatelliR.H. SexsonK. McCrindleB.W. LamC. DragulescuA. YoungR.S.M. GamulkaB. KrishnanA. AndersonB.R. FarooqiK.M. ShaktiD. ParnellA.S. OsakweO.J. SykesM.C. MorganL. OwadaC.Y. ForshaD. CarrM.R. WatanabeK. PortmanM.A. DummerK.B. BurnsJ.C. TremouletA.H. SharmaK. JoneP-N. HeizerM.H.H. HasbaniK. SrivastavaS. MitchellE.C. HebsonC.L. SzmuszkoviczJ.R. WongP.C. ChengA.L. Votava-SmithJ.K. WangS. MohandasS. SinghG.K. AggarwalS. SanilY. BradfordT.T. MunizJ.C.G. LiJ.S. CampbellM.J. HandlerS.S. SheaJ.R. HoffmanT.M. FranklinW.J. SabatiA.A. NowlenT.T. ChrisantM. MUSIC Study Investigators (Supplement 1) The NHLBI study on long-term outcomes after the multisystem inflammatory syndrome in children (MUSIC): Design and objectives.Am. Heart J.2022243435310.1016/j.ahj.2021.08.00334418362
     [Google Scholar]
/content/journals/cpr/10.2174/0115733963314978240923110844
Loading
Cardiology Consult for the General Pediatrician after Cardiac Manifestations from a SARS-CoV-2 Infection
Curr Pediatr Rev 22, 11 (2026); https://doi.org/10.2174/0115733963314978240923110844
/content/journals/cpr/10.2174/0115733963314978240923110844
/content/journals/cpr/10.2174/0115733963314978240923110844
Loading

Data & Media loading...


  • Article Type:     Review Article
Keyword(s): acute SARS-CoV-2; COVID-19; long COVID-19 syndrome; MIS-C; myocarditis; Pediatrics

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test